首页> 美国卫生研究院文献>Avicenna Journal of Phytomedicine >Neuropharmacological effects of standardized aqueous stem bark extract of Parkia biglobossa in Wistar rats
【2h】

Neuropharmacological effects of standardized aqueous stem bark extract of Parkia biglobossa in Wistar rats

机译:大白鼠标准含水茎皮提取物对Wistar大鼠的神经药理作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective: Parkia biglobossa stem bark decoction is a popular medicinal plant preparation used as calming agent for tensed patients in traditional medicine. The aim of this study was to evaluate the effects of aqueous stem bark extract of Parkia biglobossa (AEPB) and its active fraction AEPBF3 on anxiety, spontaneous alternation behavior, and locomotor activity. The open field apparatus was used to evaluate effects of AEPB and AEPBF3 on locomotion. The APBE and the active fraction AEPBF3 were standardized using reverse phase high performance liquid chromatography to establish finger print to ascertain identity and stability of the extracts over time. >Materials and Methods: The oral median lethal doses (LD50) of AEPB and AEPBF3 were evaluated using modified Lorke’s method in rats. The effect of APBE (50-200 mg/kg p.o.), APBEF3 (25 and 50 mg/kg p.o.), diazepam (2.5 mg/kg, i.p.), and 10 ml normal saline/kg on anxiety-like behavior, spontaneous alternation behavior, and locomotion activity were evaluated in rats on elevated plus maze (EPM), Zero-maze, Y-maze, and open field apparatus, respectively. The oral LD50 values of AEPB and AEPBF3 were estimated to be 5000 mg/kg and 3800 mg/kg body weight in rats, respectively. >Results: AEPB and AEPBF3 significantly (F6, 41=2342, p<0.0001) increased time spent in the open arm of EPM and significantly (F6, 41=2323, p<0.0001) increased time spent in open arms of the Zero maze. The AEPB and AEPBF3 administration produced significant increase (F5, 35=154, p<0.0001) in spontaneous alternation behavior in rats. The AEPB extract and its fraction AEPBF3 significantly increased total locomotor activity (F6, 41=413, p<0.0001) and rearing (F6, 41=150, p<0.0001) in the open field apparatus. >Conclusion: The results of the present study provided evidence for anxiolytic and nootropic effects of the AEPB and AEPBF3, thus providing scientific basis for its continuous use in the management of neuropsychiatric disorders characterized by apprehension and amnesia.
机译:>目的:Parkia biglobossa茎皮汤剂是一种流行的药用植物制剂,可用作传统医学中紧张患者的镇静剂。这项研究的目的是评估Parkia biglobossa(AEPB)的含水树皮提取物及其有效成分AEPBF3对焦虑,自发交替行为和运动能力的影响。使用开放式仪器评估AEPB和AEPBF3对运动的影响。使用反相高效液相色谱法对APBE和活性级分AEPBF3进行标准化,以建立指纹图谱,以确定提取物随时间的身份和稳定性。 >材料和方法:采用改良的Lorke方法在大鼠中评估AEPB和AEPBF3的口服中值致死剂量(LD50)。 APBE(口服50-200 mg / kg),APBEF3(口服25和50 mg / kg),地西epa(2.5 mg / kg,腹膜内)和10 ml生理盐水/ kg对焦虑样行为,自发交替的影响在高架迷宫(EPM),零迷宫,Y迷宫和开阔野设备上分别评估了大鼠的行为和运动活动。在大鼠中,AEPB和AEPBF3的口服LD50值分别估计为5000 mg / kg和3800 mg / kg体重。 >结果:AEPB和AEPBF3显着(F6,41 = 2342,p <0.0001)增加了在EPM开放臂上的时间,而显着(F6,41 = 2323,p <0.0001)零迷宫张开双臂。 AEPB和AEPBF3的给药使大鼠的自发交替行为显着增加(F5,35 = 154,p <0.0001)。 AEPB提取物及其级分AEPBF3显着提高了开放田间设备的总运动能力(F6,41 = 413,p <0.0001)和饲养(F6,41 = 150,p <0.0001)。 >结论:本研究结果为AEPB和AEPBF3的抗焦虑和促智作用提供了证据,从而为其继续用于治疗以焦虑和健忘为特征的神经精神疾病提供了科学依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号